- $26.05m
- $6.16m
- $1.98m
- 75
- 31
- 22
- 37
Annual balance sheet for CIBL, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 29.3 | 26.9 | 22.7 | 22.7 | 20.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.236 | 0.181 | 0.268 | 0.273 | 0.284 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 29.9 | 27.5 | 23.2 | 23.2 | 21.4 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.15 | 0.847 | 0.676 | 0.646 | 0.958 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 31.7 | 28.9 | 24.5 | 25 | 24.5 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.331 | 0.495 | 0.48 | 0.447 | 0.436 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.653 | 0.677 | 0.55 | 0.543 | 0.482 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 31 | 28.2 | 23.9 | 24.5 | 24 |
| Total Liabilities & Shareholders' Equity | 31.7 | 28.9 | 24.5 | 25 | 24.5 |
| Total Common Shares Outstanding |